99 related articles for article (PubMed ID: 8783677)
21. Clinical predictors of the leading pathogens in human immunodeficiency virus-infected adults with community-onset bacteremia in the emergency department: The importance of transmission routes.
Lee CC; Chou YJ; Lin JN; Chu FY; Tang HJ; Lai CH; Lin HH; Hung CC; Ko WC
J Microbiol Immunol Infect; 2018 Jun; 51(3):392-400. PubMed ID: 28082067
[TBL] [Abstract][Full Text] [Related]
22. Clinical parameters associated with low bacteremia risk in 1100 pediatric oncology patients with fever and neutropenia.
Baorto EP; Aquino VM; Mullen CA; Buchanan GR; DeBaun MR
Cancer; 2001 Aug; 92(4):909-13. PubMed ID: 11550165
[TBL] [Abstract][Full Text] [Related]
23. Changes in the epidemiology of pneumococcal bacteremia in a Swiss university hospital during a 15-year period, 1986-2000.
Trampuz A; Widmer AF; Fluckiger U; Haenggi M; Frei R; Zimmerli W
Mayo Clin Proc; 2004 May; 79(5):604-12. PubMed ID: 15132401
[TBL] [Abstract][Full Text] [Related]
24. Opportunistic infection and immunologic function in patients with human immunodeficiency virus-associated non-Hodgkin's lymphoma treated with chemotherapy.
Sparano JA; Hu X; Wiernik PH; Sarta C; Reddy DM; Hanau L; Henry DH
J Natl Cancer Inst; 1997 Feb; 89(4):301-7. PubMed ID: 9048834
[TBL] [Abstract][Full Text] [Related]
25. Long-term central venous catheter infection in HIV-infected and cancer patients: a multicenter cohort study.
Astagneau P; Maugat S; Tran-Minh T; Douard MC; Longuet P; Maslo C; Patte R; Macrez A; Brücker G
Infect Control Hosp Epidemiol; 1999 Jul; 20(7):494-8. PubMed ID: 10432162
[TBL] [Abstract][Full Text] [Related]
26. Epidemiologic changes in bacteremic pneumococcal disease in patients with human immunodeficiency virus in the era of highly active antiretroviral therapy.
Grau I; Pallares R; Tubau F; Schulze MH; Llopis F; Podzamczer D; Liñares J; Gudiol F;
Arch Intern Med; 2005 Jul; 165(13):1533-40. PubMed ID: 16009870
[TBL] [Abstract][Full Text] [Related]
27. Intravenous immune globulin for the prevention of bacterial infections in children with symptomatic human immunodeficiency virus infection.
National Institute of Child Health and Human Developments Intravenous Immunoglobulin Study Group
N Engl J Med; 1991 Jul; 325(2):73-80. PubMed ID: 1675763
[TBL] [Abstract][Full Text] [Related]
28. Neutropenia during therapy with peginterferon and ribavirin in HIV-infected subjects with chronic hepatitis C and the risk of infections.
Serrano-Villar S; Quereda C; Moreno A; Pérez-Elías MJ; Casado JL; Royuela A; Dronda F; Navas E; Hermida JM; Moreno S
Clin Infect Dis; 2013 Aug; 57(3):458-64. PubMed ID: 23575196
[TBL] [Abstract][Full Text] [Related]
29. Bacteremia in patients with hematological malignancies. Analysis of risk factors, etiological agents and prognostic indicators.
Pagano L; Tacconelli E; Tumbarello M; Laurenti L; Ortu-La Barbera E; Antinori A; Caponera S; Cauda R; Leone G
Haematologica; 1997; 82(4):415-9. PubMed ID: 9299853
[TBL] [Abstract][Full Text] [Related]
30. Campylobacter jejuni bacteremia in human immunodeficiency virus (HIV)-infected and non-HIV-infected patients: comparison of clinical features and review.
Tee W; Mijch A
Clin Infect Dis; 1998 Jan; 26(1):91-6. PubMed ID: 9455515
[TBL] [Abstract][Full Text] [Related]
31. Bronchopulmonary infection with Pseudomonas aeruginosa in patients infected with human immunodeficiency virus.
Ali NJ; Kessel D; Miller RF
Genitourin Med; 1995 Apr; 71(2):73-7. PubMed ID: 7744417
[TBL] [Abstract][Full Text] [Related]
32. Etiology of neutropenia in HIV-infected patients.
Jaresko GS
Am J Health Syst Pharm; 1999 Dec; 56 Suppl 5():S5-8. PubMed ID: 10613380
[TBL] [Abstract][Full Text] [Related]
33. Seroprevalence of viral hepatitis and infectious complications among human immunodeficiency virus-infected injection drug users at a referral hospital.
Liang SH; Lo YC; Lin HH; Chang SY; Chen MY; Hsieh SM; Sheng WH; Sun HY; Hung CC; Chang SC
J Microbiol Immunol Infect; 2008 Jun; 41(3):200-8. PubMed ID: 18629414
[TBL] [Abstract][Full Text] [Related]
34. Emesis predicts bacteremia in immunocompromised children with central venous catheters and fever.
Richardson MW; Grewal SS; Visintainer PF
Cancer; 2009 Jul; 115(14):3335-40. PubMed ID: 19449369
[TBL] [Abstract][Full Text] [Related]
35. Bacteremia due to multiresistant gram-negative bacilli in neutropenic cancer patients: a case controlled study.
Krcméry V; Spanik S; Krupova I; Trupl J; Kunova A; Smid M; Pichnova E
J Chemother; 1998 Aug; 10(4):320-5. PubMed ID: 9720472
[TBL] [Abstract][Full Text] [Related]
36. Epidemiology of device-associated infections related to a long-term implantable vascular access device.
Sotir MJ; Lewis C; Bisher EW; Ray SM; Soucie JM; Blumberg HM
Infect Control Hosp Epidemiol; 1999 Mar; 20(3):187-91. PubMed ID: 10100545
[TBL] [Abstract][Full Text] [Related]
37. Incidence of Mycobacterium avium-intracellulare complex bacteremia in human immunodeficiency virus-positive patients.
Nightingale SD; Byrd LT; Southern PM; Jockusch JD; Cal SX; Wynne BA
J Infect Dis; 1992 Jun; 165(6):1082-5. PubMed ID: 1349906
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of febrile, nonneutropenic pediatric oncology patients with central venous catheters who are not given empiric antibiotics.
Bartholomew F; Aftandilian C; Andrews J; Gutierrez K; Luna-Fineman S; Jeng M
J Pediatr; 2015 Jan; 166(1):157-62. PubMed ID: 25444524
[TBL] [Abstract][Full Text] [Related]
39. Pseudomonas bacteremia precipitated by ticlopidine-induced neutropenia.
Geletko SM; Melbourne KM; Mikolich DJ
Ann Pharmacother; 1996 Mar; 30(3):246-8. PubMed ID: 8833559
[TBL] [Abstract][Full Text] [Related]
40. The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection. A double-blind, placebo-controlled trial. The AIDS Clinical Trials Group.
Fischl MA; Richman DD; Hansen N; Collier AC; Carey JT; Para MF; Hardy WD; Dolin R; Powderly WG; Allan JD
Ann Intern Med; 1990 May; 112(10):727-37. PubMed ID: 1970466
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
